Superworth

Scynexis profit margin SCYX

Gross, operating and net profit as a share of revenue over the last twelve months, from 2014.

Net margin, 12 months
−53.3%
Peer median
3.7%

Over the twelve months to Jun 30, 2026, Scynexis kept −53.3% of its revenue as net profit.

The median for 4 large drugmakers of a similar size is 3.7%.

Profit margin over time

GrossOperatingNet

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearNet marginOperating marginGross margin
FY2025−41.8%−77.9%n/a
FY2024n/an/an/a
FY202347.8%51.9%n/a
FY2022n/an/an/a
FY2021n/an/an/a
FY2020n/an/an/a
FY2019n/an/an/a
FY2018n/an/an/a
FY2017n/an/an/a
FY2016n/an/an/a
FY2015n/an/an/a
FY2014−41.8%n/a35.3%
FY2013n/a−42.7%3.3%

Quarter by quarter

QuarterEndedNet margin, 12 monthsChange on a yearOperating margin
Q2 FY26−53.3%n/an/a
Q1 FY26n/an/an/a
Q4 FY25−41.8%n/a−77.9%
Q3 FY25n/an/an/a
Q2 FY25n/an/an/a
Q1 FY25n/an/an/a
Q4 FY24n/an/an/a
Q3 FY24n/an/an/a
Q2 FY24n/an/an/a
Q1 FY2472.2%n/a52.6%
Q4 FY2347.8%n/a51.9%
Q3 FY2353.1%n/a53.9%

Against its peers

Companies in Drug Manufacturers - General nearest Scynexis' size, closest first, today.

CompanyProfit margin
SCYXScynexis−53.3%
ATNMActinium Pharmaceuticalsn/m
SPROSpero Therapeutics15.7%
LFVNLifevantage2.8%
NATRNatures Sunshine Products3.7%
Peer median3.7%

What the profit margin tells you

Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).

Compare within an industry. 10% is superb for a retailer and poor for a software company.

More on Scynexis

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.